Monograph Title | Section | Source Publication | Page Number | Errata Post Date | Errata Official Date Sort ascending | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
ERYTHROMYCIN ETHYLSUCCINATE FOR ORAL SUSPENSION | Assay | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | Change Constitute Erythromycin Ethylsuccinate for Oral Suspension as directed in the labeling, and proceed as directed in the Assay under Erythromycin Ethylsuccinate Oral Suspension. to: Constitute Erythromycin Ethylsuccinate for Oral… Read More |
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Test 2/Analysis: Change CS = concentration of USP Norethindrone Acetate RS (mg/mL) or USP Ethinyl Estradiol RS (ug/mL) in the Standard solution to: CS = concentration of USP Norethindrone Acetate… Read More |
ERYTHROMYCIN DELAYED-RELEASE TABLETS | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Test 1: Change Buffer stage Medium: 0.05 M pH 6.8 phosphate buffer (see Reagents, Indicators, and Solutions—Buffer Solutions) to: Buffer stage Medium: 0.05 M pH 6.8 phosphate buffer (see Reagents,… Read More |
CALCIUM LACTATE | CHEMICAL INFORMATION | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | Change Calcium lactate (1:2) hydrate to: Calcium lactate hydrate AND Change Calcium lactate (1:2) pentahydrate to: Calcium lactate pentahydrate |
THYROID | ASSAY/Procedure | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Chromatographic system: Change Column: 4.6-cm × 25-cm; packing L1 to: Column: 4.6-mm × 25-cm; packing L1 |
PRAZOSIN HYDROCHLORIDE CAPSULES | ASSAY/Procedure | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Analysis: Change CS = concentration of USP Prazosin Hydrochloride RS in the Standard solution (µg/mL) CU = nominal concentration of prazosin in the Sample solution (µg/mL) Mr1… Read More |
METAPROTERENOL SULFATE TABLETS | Identification/A. | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | Change Proceed as directed in Identification test A under Metaproterenol Sulfate Inhalation Solution, beginning with “Allow the spots to dry”: to: Allow the spots to dry, and develop the chromatogram in a solvent system consisting… Read More |
MIRTAZAPINE TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | In System suitability/Suitability requirements/Resolution: Change 10-ketomirtazpine to: 10-ketomirtazapine AND In Table 1: Change 1-Ketomirtazpinec to: 1-Ketomirtazapinec |
METAPROTERENOL SULFATE ORAL SOLUTION | Identification/A. | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | Change Proceed as directed in Identification test A under Metaproterenol Sulfate Inhalation Solution, beginning with “Allow the spots to dry”: to: Allow the spots to dry, and develop the chromatogram in a solvent system consisting… Read More |
SOTALOL HYDROCHLORIDE | IMPURITIES/Organic Impurities | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | In Analysis: Change Calculate the percentage of any unspecified impurities in the portion of Sotalol Hydrochloride taken: Result = (rU/rS) × (CS/CU) × 100 r… Read More |
LIDOCAINE HYDROCHLORIDE AND DEXTROSE INJECTION | Assay for lidocaine hydrochloride | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | Change Proceed with Injection as directed in the Assay for lidocaine hydrochloride under Lidocaine and Epinephrine Injection. to: Proceed with Injection as directed in the Assay for lidocaine hydrochloride under Lidocaine… Read More |
AZTEC MARIGOLD ZEAXANTHIN EXTRACT | COMPOSITION/Procedure 4: Stereoisomeric Composition | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In System suitability/Suitability requirements/Resolution: Change (3R,3′S meso)-zeaxanthin to: (3R,3′S)-zeaxanthin AND In Analysis: Change (3R,3′S … Read More |
ISOBUTYL ALCOHOL | ASSAY/Procedure | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Analysis: Change rS = sum of all the peaks except those each of which with an area less than 0.1 times the area of the major peak from the Reference solution to: rT = sum of all the peaks except those… Read More |
FLUTICASONE PROPIONATE NASAL SPRAY | IMPURITIES/Organic Impurities | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Analysis: Change Samples: System suitability solution, Identification solution, and Sample solution to: Samples: Identification solution and Sample solution |
MESO-ZEAXANTHIN PREPARATION | COMPOSITION/Stereoisomeric Composition | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In System suitability: Change [Note—The approximate relative retention times for (3S,3′S)-zeaxanthin, (3R,3′S-meso)-zeaxanthin, (3R,3′R)-zeaxanthin, and (3R,3′R,6′R)-lutein are 0.94… Read More |
METARAMINOL BITARTRATE | SPECIFIC TESTS/Content of Tartaric Acid | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Analysis: Change Result = {[(VS−VB) × N × F]/2 × W} × 100 to: Result = {[(VS−VB) × N × F]/(2 × W)} × 100 |
CHLOROPROCAINE HYDROCHLORIDE INJECTION | ASSAY/Procedure | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Sample solution: Change Transfer about 100 mg of chloroprocaine hydrochloride to a 100-mL volumetric flask, dissolve in 40 mL of methanol, and dilute with water to volume. to: Transfer a volume of Injection, equivalent to about 100 mg of… Read More |
POLYETHYLENE GLYCOL STANDARDS WITH MOLECULAR WEIGHTS OF 1000, 2000, 3000, 4000, AND 6000 DALTONS (G/MOL) | CHEMICAL INFORMATION | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | Change CAS RN®: 25332-68-3. to: CAS RN®: 25322-68-3. |
DEXAMETHASONE SODIUM PHOSPHATE INJECTION | ASSAY/Procedure | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Analysis: Change Result = (rU/rS) × (CS/CU) × (Mr1/Mr22) × 100 to: Result = (rU/r… Read More |
MESO-ZEAXANTHIN PREPARATION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In USP meso-Zeaxanthin RS: Change (3R,3′S-meso)-Zeaxanthin. to: (3R,3′S)-Zeaxanthin. |
AZTEC MARIGOLD ZEAXANTHIN EXTRACT | IDENTIFICATION/C. | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | Change (3R,3′S meso)-zeaxanthin to: (3R,3′S)-zeaxanthin |
METARAMINOL BITARTRATE | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In USP Metaraminol Enantiomer RS: Change 3-[(1S,2R)-2-Amino-1-hydroxypropyl]phenol. C9H13NO2 167.21 to: 3-[(1S,2R)-2-Amino-1-hydroxypropyl]phenol D-tartrate. C9H… Read More |
MESO-ZEAXANTHIN PREPARATION | IDENTIFICATION/C. | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | Change (3R,3′S-meso)-zeaxanthin to: (3R,3′S)-zeaxanthin |
POTASSIUM GLUCONATE ORAL SOLUTION | SPECIFIC TESTS | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | Change Alcohol Determination 〈611〉, Method II—Distillation Method: to: Alcohol Determination 〈611〉, Method I—Distillation Method: |
Methyl Acetate | CHEMICAL INFORMATION | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | Change CAS RN®: 74-20-9. to: CAS RN®: 79-20-9. |
PALONOSETRON HYDROCHLORIDE | IMPURITIES | USPNF Online | Online | 16-Dec-2022 | 1-Jan-2023 | NA | NA | In Limit of Unspecified Impurities: Change Mobile phase and Chromatographic system: Proceed as directed in the Assay. to: Mobile phase, Standard stock solution, and Chromatographic system: Proceed… Read More |
METOLAZONE TABLETS | ASSAY/Procedure | USPNF Online | Online | 16-Dec-2022 | 1-Jan-2023 | NA | NA | In Buffer: Change 1.38 g of monobasic potassium phosphate monohydrate in 900 mL of water. to: 1.38 g of monobasic sodium phosphate in 900 mL of water. |
MAFENIDE ACETATE FOR TOPICAL SOLUTION | IMPURITIES/Organic Impurities | USPNF Online | Online | 16-Dec-2022 | 1-Jan-2023 | NA | NA | In System suitability: Change Samples: System suitability solution, Standard solution A, and Standard solution B to: Samples: System suitability solution and Standard solution A AND … Read More |
0.1 M ZINC SULFATE VS | STANDARDIZATION | USPNF Online | Online | 26-Aug-2022 | 1-Dec-2022 | NA | NA | In Standardization with visual end point: Change M = mL edetate disodium × edetate disodium/mL ZnSO4 to: M = mL edetate disodium × M edetate disodium/mL ZnSO4 AND In Standardization with potentiometric end point… Read More |
ZINC UNDECYLENATE | ASSAY/Procedure | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | In Solution A: Change 0.15 N hydrochloric acid in water prepared as follows. Transfer 150 mL of hydrochloric acid to a 500-mL volumetric flask, dilute with water to volume, and mix well. to: 0.15 N hydrochloric acid in water prepared as follows.… Read More |
PENICILLIN G BENZATHINE AND PENICILLIN G PROCAINE INJECTABLE SUSPENSION | IDENTIFICATION | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | In Test A: Change It responds to the Identification test under Penicillin G Benzathine Oral Suspension: the spot obtained from the test solution, corresponding in RF value to that obtained from the Standard solution, is… Read More |
<621> CHROMATOGRAPHY | ADJUSTMENT OF CHROMATOGRAPHIC CONDITIONS | USPNF Online | Online | 26-Aug-2022 | 1-Dec-2022 | NA | NA | In Liquid Chromatography: Isocratic Elution/Injection volume: Change L2 = internal diameter of the column used (mm) dc1 = particle size indicated in the monograph (µm) dc2 =… Read More |
ENZACAMENE | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Dec-2022 | NA | NA | In Analysis: Change CU = concentration of enzacamene in the Sample solution (mg/mL) to: CU = concentration of Enzacamene in the Sample solution (mg/mL) |
NALOXONE HYDROCHLORIDE | IMPURITIES | USPNF Online | Online | 28-Oct-2022 | 1-Dec-2022 | NA | NA | In Limit of Naloxone Related Compound D: Delete Sensitivity solution: 1.25 µg/mL of USP Naloxone Related Compound D RS in 0.1 N hydrochloric acid AND In System suitability/Samples: Delete Sensitivity solution,… Read More |
POTASSIUM CITRATE EXTENDED-RELEASE TABLETS | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | In Test 6: Change Times: 0.5, 1, and 4 h—for strengths 540 and 1080 mg as potassium citrate monohydrate; 0.5, 1, and 6 h—for strength 1620 mg as potassium citrate monohydrate. to: Times: 0.5, 1, and 4 h—for strength 540 mg as potassium… Read More |
N-Benzoyl-L-arginine Ethyl Ester Hydrochloride | REAGENT SPECIFICATIONS | USPNF Online | Online | 30-Sep-2022 | 1-Dec-2022 | NA | NA | Change Crystallized Trypsin (USP Monograph). to: Trypsin (USP Monograph). |
ROCURONIUM BROMIDE | IMPURITIES/Organic Impurities | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | USPNF 2023 Issue 3 | In footnote b of Table 1: Change 2β-(Morpholin-4-yl)-16β-(pyrrolidin-1-yl)-5α-androstan-3α,17β-diol. to: 2β-(Morpholin-4-yl)-16β-(pyrrolidin-1-yl)-5α-androstane-3α,17β-diol. |
LATANOPROST | ASSAY/Procedure | USPNF Online | Online | 29-Jul-2022 | 1-Dec-2022 | NA | NA | Change Standard solution: Transfer 2.0 mg/mL of USP Latanoprost RS into a suitable volumetric flask, dissolve in dehydrated alcohol equivalent to 20% of the final volume, and dilute with chromatographic hexane to volume. Sample solution:… Read More |
CHLORHEXIDINE GLUCONATE ORAL RINSE | IMPURITIES/Limit of p-Chloroaniline | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | Change Standard solution: 1.0 µg/mL of USP p-Chloroaniline RS in Diluent to: Standard solution: 0.001 mg/mL of USP p-Chloroaniline RS in Diluent AND In Analysis: Change Result = (rU… Read More |
MOMETASONE FUROATE TOPICAL SOLUTION | IDENTIFICATION | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | In test A: Change The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, both relative to the internal standard, as obtained in the Assay. to: The retention time of the major… Read More |
MAGNESIUM OXIDE | IMPURITIES/Limit of Calcium | USPNF Online | Online | 25-Feb-2022 | 1-Dec-2022 | NA | NA | In Analysis: Change CU = concentration of Magnesium Hydroxide in the Sample solution (mg/mL) to: CU = concentration of Magnesium Oxide in the Sample solution (mg/mL) |
FELODIPINE | IMPURITIES/Organic Impurities | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | Change Buffer, Mobile phase, System suitability solution, Standard solution, Sample solution, and Chromatographic system: Proceed as directed in the Assay. to: Buffer, Mobile phase… Read More |
PENICILLIN G BENZATHINE INJECTABLE SUSPENSION | IDENTIFICATION | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | Change It responds to the Identification test under Penicillin G Benzathine Oral Suspension. to: Mix a portion of it with methanol to obtain a solution containing about 3000 Penicillin G Units per mL. Apply 20 µL of this test solution and… Read More |
<621> CHROMATOGRAPHY | ADJUSTMENT OF CHROMATOGRAPHIC CONDITIONS | USPNF Online | Online | 29-Apr-2022 | 1-Dec-2022 | NA | NA | In Liquid Chromatography: Isocratic Elution/Injection volume: Change Result = (Vinj2 = Vinj1 (L2 dc22 )/(L1… Read More |
PRIMIDONE TABLETS | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Dec-2022 | NA | NA | In Sample solution: Change 0.05 mg/mL of primidone from the Standard stock solution in Diluent to: 0.05 mg/mL of primidone from the Sample stock solution in Diluent |
ADIPIC ACID | IMPURITIES/Related Substances | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | In Table 2: Change Pimelic acid 1.21 0.91 Valeric acid 1.21 0.91 to: Pimelic acid 1.21 0.91 Valeric acid 1.46 0.88 |
ROCURONIUM BROMIDE | CHEMICAL INFORMATION | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | USPNF 2023 Issue 3 | Change 609.68 to: 609.69 |
<621> CHROMATOGRAPHY | SYSTEM SUITABILITY | USPNF Online | Online | 25-Mar-2022 | 1-Dec-2022 | NA | NA | Change System Repeatability—Assay of an Active Substance or an Excipient to: System Repeatability |
DOXORUBICIN HYDROCHLORIDE INJECTION | IMPURITIES/Organic Impurities | USPNF 2022 Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
DOXAZOSIN MESYLATE | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change CS = concentration of the corresponding USP Doxazosin Related Compound RS or USP Doxazosin Mesylate RS (for calculating unspecified impurities) in the Standard solution (mg/mL) to: CS… Read More |